Brief: ASIT Biotech Gets GMP Certification For Liege Manufacturing Site
Oct 7 (Reuters) - ASIT BIOTECH SA ASIT.BR :
* ASIT BIOTECH RECEIVES GMP CERTIFICATION FOR ITS
MANUFACTURING
SITE IN LIEGE, BELGIUM
* GP-ASIT+ PHASE III CLINICAL TRIAL RESULT EXPECTED IN
DECEMBER
2019
Source text for Eikon: ID:nGNX2xkpv8
Further company coverage: ASIT.BR
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com;))
Recent news on European Medical Solutions SA
See all newsBrief: DMS Imaging H1 EBITDA Rises To EUR 2.2 Million
Brief: DMS Imaging Announces Resumption Of Project To Transfer Its Listing Securities On Euronext Growth Market In Paris And Brussels
Brief: DMS Imagining Announces End Of Litigation With Thierry Legon
Brief: DMS Imaging Sees 2023 Revenue At 40 Million Euros
Brief: DMS Imaging Says Fujifilm Healthcare Italy Wins Tender For Its Radiology Tables